Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00671892 · ClinicalTrials.gov registry record · Phase 1
Role of TLR4 in Environmental Asthma
A Phase 1 study of Asthma, sponsored by John Sundy.
- Completed
- Registry status
- Phase 1
- Development phase
- 855
- Enrollment target
- 1
- Study location
NCT00671892: Completed Phase 1 study of Asthma, sponsored by John Sundy.
NCT00671892 is a Phase 1 study of Asthma that has completed, run by John Sundy. The registered enrollment target is 855 participants, below the 1,561-participant average among 374 other Asthma trials with a reported enrollment target (45% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00671892, a Phase 1 study of Asthma, has completed, sponsored by John Sundy.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 855 participants
- Enrollment target
- 1
- Study location
Study Summary
The overall goal of this project is to identify genes that are involved in the development of airflow obstruction and airway inflammation in asthmatics, and to determine whether polymorphisms in these differentially expressed genes predispose individuals to develop asthma. In this project, we hypothesize that polymorphisms of genes expressed by the airway epithelia in asthmatics following specific airway challenges predispose individuals to the development of asthma.
Conditions Studied
Interventions
- BIOLOGICAL Lipopolysaccharide endotoxin
Study Locations (1)
North Carolina
- Duke University Medical Center - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 855 participants |
| Start Date | 2001-09 |
| Est. Completion | 2008-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00671892
The ClinicalTrials.gov registry entry for NCT00671892 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 855 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,561-participant average among 374 other Asthma trials with a reported enrollment target (45% lower). The listed sponsor is John Sundy, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 1 intervention - of which Lipopolysaccharide endotoxin is the first listed.
NCT00671892 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.
Frequently Asked Questions
What is clinical trial NCT00671892 about?
NCT00671892 is a clinical study titled "Role of TLR4 in Environmental Asthma". The overall goal of this project is to identify genes that are involved in the development of airflow obstruction and airway inflammation in asthmatics, and to determine whether polymorphisms in these differentially expressed genes predispose individuals to develop asthma. In this project, we hypoth...
What is the current status of trial NCT00671892?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 855 participants. The study started on 2001-09. Estimated completion is 2008-04.
What conditions does trial NCT00671892 study?
This clinical trial studies the following conditions: Asthma.
What interventions are being tested in trial NCT00671892?
The interventions under investigation include: Lipopolysaccharide endotoxin (BIOLOGICAL).
Who is sponsoring clinical trial NCT00671892?
This trial is sponsored by John Sundy, which has 6 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00671892 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease
RECRUITING · Phase 1
-
A Study to Investigate How Budesonide and Formoterol Move Through the Body (Pharmacokinetics) When Delivered With Different Devices in Participants Aged 4 to Less Than 12 Years Old With Asthma
RECRUITING · Phase 1
-
Pilot Study to Identify the Mediators and Inflammatory Cell Surface Receptors Involved in Allergic Airway Inflammation
RECRUITING · Phase 1
-
A Phase 1, Randomized, Double-blind, Placebo-controlled Study Evaluating AMG 691 in Healthy Participants and Participants With Mild-to-Moderate Asthma
RECRUITING · Phase 1
-
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Immunogenicity of APG777 in Adults With Asthma
ACTIVE NOT RECRUITING · Phase 1
-
A Study to Investigate GB-0895 in Adults With Mild to Moderate Asthma or COPD
ACTIVE NOT RECRUITING · Phase 1
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.